COVID-19 is not going to end in the way most people hoped for early in the pandemic. There will be no single moment when the virus disappears. Instead, the world has already shifted from a pandemic to an endemic phase, meaning SARS-CoV-2 now circulates permanently alongside other respiratory viruses like influenza. The WHO officially declared the end of COVID-19 as a global health emergency in May 2023, and most countries have moved from crisis response to long-term management.
What “Ending” Actually Means
When the WHO lifted the Public Health Emergency of International Concern designation, it wasn’t saying COVID-19 was gone. The emergency committee determined that the outbreak no longer met the threshold of an “extraordinary event,” which is the key criterion for that designation. WHO Director-General Tedros Adhanom Ghebreyesus put it plainly: it was time for countries to transition from emergency mode to managing COVID-19 alongside other infectious diseases.
That transition is already well underway. Population seroprevalence levels, reflecting the combined experience of prior infection and vaccination, are now above 90% in most countries. This wall of immunity is what changed the math. Despite high numbers of infections, hospitalizations and deaths no longer spike the way they did in earlier waves. In early 2022, the UK recorded 12 million cases in a single month, yet intensive care admissions stayed roughly in line with what hospitals normally see from pneumonia patients.
Why the Virus Won’t Disappear
Total eradication of SARS-CoV-2 is essentially off the table. The virus has established itself in animal populations, most notably white-tailed deer and farmed mink, which act as long-term reservoirs. Deer in some regions still carry Alpha-like lineages long after those variants vanished from human circulation. These animal hosts give the virus time and space to mutate in directions that human immunity doesn’t constrain, creating the possibility of lineages that look very different from what’s currently circulating in people.
This transforms SARS-CoV-2 from a purely human problem into a network of linked epidemics across species. Humans remain the largest host population, but no longer the virus’s only long-term home. As long as these reservoirs exist, the virus has places to evolve, recombine, and potentially produce new variants. New variants continue to emerge, driven by an evolutionary arms race between the virus and the human immune system. That process has no foreseeable endpoint.
COVID-19 Is Becoming Seasonal
One sign the virus is settling into an endemic pattern is that infections are becoming predictable. Across much of the temperate northern hemisphere, COVID-19 is transitioning to a seasonal cycle with higher incidence in late fall and winter and lower incidence in summer. In New York, surges are projected between October and January. In Yamagata, Japan, the peak shifts later, from January through March. These patterns mirror what we see with the four other human coronaviruses that cause common colds.
The timing varies by location, but the overall trend is consistent: summer brings relief, and cold months bring a wave. This is the pattern scientists expect to persist indefinitely.
How It Compares to the Flu Now
COVID-19 still causes significant illness, but its burden on hospitals has moved closer to what influenza and RSV produce each year. During the 2023-24 respiratory season in the United States, there were roughly 613,000 COVID-19 hospitalizations, compared to about 216,000 for influenza and 178,000 for RSV. COVID-19 remains the larger contributor, but all three viruses now co-circulate and collectively strain healthcare systems during winter months.
As of early 2026, COVID-19 accounts for about 0.6% of all deaths in the United States in a given week. That’s not zero, and for older adults and people with chronic conditions, the risk remains real. But it represents a dramatic decline from the peaks of 2020 and 2021, when COVID-19 was among the leading causes of death nationwide.
Long COVID Remains a Concern
Even as acute infections become milder for most people, long COVID continues to affect a meaningful number of those who get infected. A 2025 study from the Barcelona metropolitan area found that among people diagnosed with long COVID, 64% reported still being symptomatic at the time of the survey. The most common complaints were persistent fatigue, joint pain, and difficulty concentrating. Some evidence suggests these symptoms can last four years or longer after the initial infection.
Most people who needed sick leave for COVID-19 were off work for less than a month (about 77%), but roughly 5% required more than a year away. That tail end of severe, prolonged disability is one reason public health officials still take the virus seriously even as emergency measures wind down.
What Ongoing Protection Looks Like
COVID-19 vaccination has shifted from a mass campaign to something resembling the annual flu shot. The CDC’s 2025-2026 guidance recommends updated vaccines for everyone six months and older, with the strongest emphasis on adults 65 and older (who are advised to get two doses) and people with underlying conditions that raise their risk of severe illness. For healthy adults under 65, the decision is framed as a personal one based on individual risk factors.
The expectation going forward is that population-level immunity will be dynamically maintained through a combination of periodic vaccination and natural reinfection. Scientists estimate that a seroprevalence of 60% to 70% across the population creates enough of an immunity buffer to protect the most vulnerable and keep more dangerous variants from gaining a foothold. Reinfections will continue to be common, but for most people they’ll resemble a bad cold rather than a life-threatening illness.
The Honest Answer
If “end” means the virus stops circulating entirely, that is not going to happen. SARS-CoV-2 is now a permanent part of the human respiratory virus landscape, sustained by ongoing mutation, reinfection, and animal reservoirs that give it evolutionary room to persist. If “end” means the disruption to daily life, the emergency hospital surges, and the societal upheaval, that part has already largely ended for most of the world. What remains is a virus that peaks in winter, hits hardest among older and immunocompromised people, and requires an updated vaccine each year to keep its toll manageable.